Jaejin An to Cardiovascular Diseases
This is a "connection" page, showing publications Jaejin An has written about Cardiovascular Diseases.
Connection Strength
2.152
-
Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes. Am J Nephrol. 2023; 54(7-8):258-267.
Score: 0.596
-
Incidence of Atherosclerotic Cardiovascular Disease in Young Adults at Low Short-Term But High Long-Term?Risk. J Am Coll Cardiol. 2023 Feb 21; 81(7):623-632.
Score: 0.586
-
Cardiovascular Outcomes Associated with Lowering Low-density Lipoprotein Cholesterol in Rheumatoid Arthritis and Matched Nonrheumatoid Arthritis. J Rheumatol. 2016 11; 43(11):1989-1996.
Score: 0.374
-
Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting. Arthritis Care Res (Hoboken). 2016 05; 68(5):629-37.
Score: 0.365
-
Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease. Pharmacotherapy. 2021 12; 41(12):998-1008.
Score: 0.134
-
Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency. JAMA Intern Med. 2017 04 01; 177(4):491-499.
Score: 0.097